The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma-Reference-Cited by-同舟云学术

The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

Published:2020-08-14 Issue: Volume: Page:1-8
ISSN:1018-8665
Container-title:Dermatology
language:en
Short-container-title:Dermatology

Author:

Stolearenco Veronica,Levring Trine B.,Nielsen Helene Myrtue,Lindahl Lise,Fredholm Simon,Kongsbak-Wismann Martin,Willerslev-Olsen Andreas,Buus Terkild B.,Nastasi Claudia,Hu Tengpeng,Gluud Maria,Côme Christophe R.M.,Krejsgaard Thorbjørn,Iversen Lars,Bonefeld Charlotte Menné,Grønbæk Kirsten,Met Özcan,Woetmann Anders,Ødum Niels,Geisler Carsten

Publisher

S. Karger AG

Subject

Dermatology

Reference43 articles.

1. Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016 Jan;91(1):151–65.

2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2019;133(16):1703–14.

3. Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L, et al. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Semin Immunopathol. 2017 Apr;39(3):269–82.

4. Odum N, Lindahl LM, Wod M, Krejsgaard T, Skytthe A, Woetmann A, et al. Investigating heredity in cutaneous T-cell lymphoma in a unique cohort of Danish twins. Blood Cancer J. 2017 Jan;7(1):e517.

5. Wang L, Ni X, Covington KR, Yang BY, Shiu J, Zhang X, et al. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet. 2015 Dec;47(12):1426–34.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic plasticity of malignant T cells in blood and skin of a Sézary syndrome patient revealed by single cell transcriptomics;Frontiers in Oncology;2023-01-25

2. Fluoxetine increases astrocytic glucose uptake and glycolysis in corticosterone-induced depression through restricting GR-TXNIP-GLUT1 Pathway;Frontiers in Pharmacology;2022-08-29

3. Txnip deficiency promotes β-cell proliferation in the HFD-induced obesity mouse model;Endocrine Connections;2022-04-01

4. Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition;Pharmacological Research;2022-03

5. Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP;Cell Cycle;2022-02-13